The Weekly Options Trader

Domino’s (DPZ) flashy stunts don’t seem to be working. The pizza company’s quarterly results broadly missed Wall Street’s expectations, sending shares of the company

The Global Ambulatory Blood Pressure Monitoring Market size is expected to reach $1.8 billion by 2024, rising at a market growth of 8.1% CAGR during the forecast period – PRNewswire

February 21, 2019February 22, 2019

Posted By: Admin news from the market

NEW YORK, Feb. 21, 2019 /PRNewswire/ — The Global Ambulatory Blood Pressure Monitoring Market size is expected to reach $1.8 billion by 2024, rising

The Global Hemodialysis Catheters Market size is expected to reach $ 892.4 million by 2024, rising at a market growth of 4.7% CAGR during the forecast period – PRNewswire

February 21, 2019February 22, 2019

Posted By: Admin news from the market

NEW YORK, Feb. 21, 2019 /PRNewswire/ — The Global Hemodialysis Catheters Market size is expected to reach $ 892.4 million by 2024, rising at

The single-use airway diagnostic devices market will register a CAGR of over 8% by 2023 – PRNewswire

February 21, 2019February 22, 2019

Posted By: Admin news from the market

NEW YORK, Feb. 21, 2019 /PRNewswire/ — About this market Lung disorders such as lunh cancer, tuberculosis, and pneumonia can affect the airways and

Why has Craig Kimbrel's free agent market been so quiet? Numbers show his days as a lockdown closer are likely over – CBS Sports

February 21, 2019February 22, 2019

Posted By: Admin news from the market

Time was when a decorated, frontline closer like Craig Kimbrel would have long ago been snatched up from the market. This, however, is the

Fort St. John readies to put Condill property on the market – Alaska Highway News

February 21, 2019February 22, 2019

Posted By: Admin news from the market

https://lh5.googleusercontent.com/proxy/yUH5Jz1LvKYexn5rCAGbLg8K6meOQt33iMCVTpHltS9WszH6TIVifOP9T83prex9m9I1Y2nqa8e94j-C60JKEc80y_xAQ7WERwjm6vZs-cl1_RnmkSRh6QT0612x6l3U_biEP2XtMCgysPsNYgLKcnyZO56JtCsmk2I9r6JfrVd6c-hipaDXtTLI1RTETskNfibZZATY7oyu0rvUkUgPKLKvLiX-C_EU=-w150-h150-c Fort St. John city staff are looking for council approval to declare the former Condill Hotel property as surplus and get it ready

Europe Orthodontics Supplies Market Forecast to 2024 – Set to Record Growth of 7.8% CAGR – ResearchAndMarkets.com – Business Wire

February 21, 2019February 22, 2019

Posted By: Admin news from the market

DUBLIN–(BUSINESS WIRE)–The “Europe Orthodontics Supplies Market (2018 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The Europe Orthodontics Supplies Market is expected to

The European Hemodialysis Catheters Market to 2024: Set to Record a CAGR of 4.2% – ResearchAndMarkets.com – Business Wire

February 21, 2019February 22, 2019

Posted By: Admin news from the market

DUBLIN–(BUSINESS WIRE)–The “Europe Hemodialysis Catheters Market (2018 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The Europe Hemodialysis Catheters Market is expected to

The Patient Engagement Solutions Market in Europe (2018-2024): Anticipated to Record Growth of 21.3% CAGR During the Forecast Period – ResearchAndMarkets.com – Business Wire

February 21, 2019February 22, 2019

Posted By: Admin news from the market

DUBLIN–(BUSINESS WIRE)–The “Europe Patient Engagement Solutions Market (2018 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The Europe Patient Engagement Solutions Market is

The 2019 European Infant Phototherapy Devices Market: 2018-2024 Analysis & Outlook – ResearchAndMarkets.com – Business Wire

February 21, 2019February 22, 2019

Posted By: Admin news from the market

DUBLIN–(BUSINESS WIRE)–The “Europe Infant Phototherapy Devices Market (2018 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The Europe Infant Phototherapy Devices Market is

The Weekly Options Trader is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of The Weekly Options Trader are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of The Weekly Options Trader websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.

Disclaimer: Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and TheWeeklyOptionsTrader.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.